{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05415696",
            "orgStudyIdInfo": {
                "id": "IRB-64391"
            },
            "secondaryIdInfos": [
                {
                    "id": "PROS0108",
                    "type": "OTHER",
                    "domain": "Stanford OnCore"
                }
            ],
            "organization": {
                "fullName": "Stanford University",
                "class": "OTHER"
            },
            "briefTitle": "Prostatic Artery Embolization for the Treatment of Lower Urinary Tract Symptoms in Prostate Cancer Patients Undergoing Radiation Therapy",
            "officialTitle": "Prostatic Artery Embolization (PAE) for the Treatment of Lower Urinary Tract Symptoms (LUTS) in Prostate Cancer Patients Undergoing Radiation Therapy",
            "therapeuticArea": [
                "Oncology and Hematology"
            ],
            "study": "prostatic-artery-embolization-for-the-treatment-of-lower-urinary-tract-symptoms-in-prostate-cancer-patients-undergoing-radiation-therapy"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-02",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2023-09-19",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2024-09",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2024-09",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2022-06-08",
            "studyFirstSubmitQcDate": "2022-06-08",
            "studyFirstPostDateStruct": {
                "date": "2022-06-13",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-02-22",
            "lastUpdatePostDateStruct": {
                "date": "2024-02-26",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Stanford University",
                "class": "OTHER"
            }
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": false,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "The purpose of this study is to learn if the prostatic artery embolization procedure can reduce urinary tract symptoms in patients with enlarged prostates and prostate cancer.",
            "detailedDescription": "PRIMARY OBJECTIVE\n\n1. To evaluate the symptomatic improvement in lower urinary tract symptoms after prostatic artery embolization (PAE)\n\nSECONDARY OBJECTIVES\n\n1. To evaluate objective measures of improved urinary obstruction after PAE: urine flow rate, prostate volume, and post-void residual\n2. To measure effects of PAE on prostate specific antigen (PSA).\n3. To evaluate if PAE reduces the prostate volume and simplifies radiation therapy\n4. To evaluate the safety of PAE performed in this patient population"
        },
        "conditionsModule": {
            "conditions": [
                "Prostate Cancer"
            ],
            "keywords": [
                "Prostatic artery embolization",
                "Lower urinary tract symptoms"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "NA"
            ],
            "designInfo": {
                "allocation": "NA",
                "interventionModel": "SINGLE_GROUP",
                "primaryPurpose": "SUPPORTIVE_CARE",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 10,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Prostatic artery embolization (PAE)",
                    "type": "OTHER",
                    "description": "Study participants will be treated with a single PAE procedure performed with Embosphere microspheres.",
                    "interventionNames": [
                        "Procedure: Prostatic artery embolization"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "PROCEDURE",
                    "name": "Prostatic artery embolization",
                    "description": "Patients will undergo PAE with 100-300 \u00b5m or 300-500 \u00b5m Embospheres following standard PAE technique performed by Interventional Radiology at Stanford University",
                    "armGroupLabels": [
                        "Prostatic artery embolization (PAE)"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Mean change from baseline in symptom score using the International Prostate Symptom Scale (IPSS)",
                    "description": "Patients will be classified into one of 3 symptom severity categories based on their total IPSS score as follows:\n\nMildly symptomatic: 0-7 Moderately symptomatic: 8-19 Severely symptomatic: 20-35",
                    "timeFrame": "2 months"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Mean change from baseline in maximal urinary flow measured",
                    "timeFrame": "at baseline, 2 months, and 12 months after intervention"
                },
                {
                    "measure": "Mean change from baseline in post-void residual measured",
                    "timeFrame": "at baseline, 2 months, and 12 months after intervention"
                },
                {
                    "measure": "Mean change from baseline in prostate volume measure",
                    "timeFrame": "at baseline, 2 months, and 12 months after intervention"
                },
                {
                    "measure": "Mean change from baseline in international prostate symptom scale to measure long term subjective outcomes measured",
                    "description": "Patients will be classified into one of 3 symptom severity categories based on their total IPSS score as follows:\n\nMildly symptomatic: 0-7 Moderately symptomatic: 8-19 Severely symptomatic: 20-35",
                    "timeFrame": "at baseline, 2 months, and 12 months after intervention"
                },
                {
                    "measure": "Mean change from baseline prostate specific antigen measure",
                    "timeFrame": "at baseline, 2 months, and 12 months after intervention"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Age \u2265 40 years and \u2264 90 years old\n* Prostate volume \u2265 40 mL and \u2264 300 mL\n* Biopsy proven prostate cancer undergoing radiation therapy\n* Diagnosis of moderate to severe lower urinary tract symptoms (LUTS) defined as at least one of the following:\n\n  1. IPSS \u2265 12 or dependent on urinary catheterization, or\n  2. IPSS Quality of Life (QoL) assessment \u2265 3, and\n  3. Qmax \u2264 12 mL/sec\n* Ability to understand and willingness to sign the written consent\n\nExclusion Criteria:\n\n* Neurogenic bladder disorder due to multiple sclerosis, Parkinson's disease, spinal cord injury, diabetes, etc., as demonstrated on urodynamic testing.\n* Detrusor muscle failure, urethral stenosis, or urinary obstruction due to causes other than prostatic obstruction, as demonstrated on urodynamic testing\n* Bladder diverticula greater than 5 cm or bladder stones greater than 2 cm\n* Other active urogenital cancer\n* Baseline serum creatinine greater than 2 mg/dL\n* Evidence of tortuous or atherosclerotic blood vessels\n* Coagulation disturbances not normalized by medical treatment\n* Allergy to iodinated contrast agents not responsive to steroid premedication regimen",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "40 Years",
            "maximumAge": "90 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Brittney Williams",
                    "role": "CONTACT",
                    "phone": "(650) 736-3688",
                    "email": "bw718@stanford.edu"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Andrew Picel, MD",
                    "affiliation": "Stanford University",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "Stanford Cancer Center",
                    "status": "RECRUITING",
                    "city": "San Francisco",
                    "state": "California",
                    "zip": "94305",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Brittney Williams",
                            "role": "CONTACT",
                            "phone": "650-736-3688",
                            "email": "bw718@stanford.edu"
                        },
                        {
                            "name": "Andrew Picel, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        },
                        {
                            "name": "Mark Buyyounousku, MD",
                            "role": "SUB_INVESTIGATOR"
                        },
                        {
                            "name": "Hilary Bagshaw, MD",
                            "role": "SUB_INVESTIGATOR"
                        },
                        {
                            "name": "Gil Hacharan, MD",
                            "role": "SUB_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 37.77493,
                        "lon": -122.41942
                    }
                }
            ]
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000011471",
                    "term": "Prostatic Neoplasms"
                },
                {
                    "id": "D000059411",
                    "term": "Lower Urinary Tract Symptoms"
                }
            ],
            "ancestors": [
                {
                    "id": "D000005834",
                    "term": "Genital Neoplasms, Male"
                },
                {
                    "id": "D000014565",
                    "term": "Urogenital Neoplasms"
                },
                {
                    "id": "D000009371",
                    "term": "Neoplasms by Site"
                },
                {
                    "id": "D000009369",
                    "term": "Neoplasms"
                },
                {
                    "id": "D000005832",
                    "term": "Genital Diseases, Male"
                },
                {
                    "id": "D000091662",
                    "term": "Genital Diseases"
                },
                {
                    "id": "D000091642",
                    "term": "Urogenital Diseases"
                },
                {
                    "id": "D000011469",
                    "term": "Prostatic Diseases"
                },
                {
                    "id": "D000052801",
                    "term": "Male Urogenital Diseases"
                },
                {
                    "id": "D000020924",
                    "term": "Urological Manifestations"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M14335",
                    "name": "Prostatic Neoplasms",
                    "asFound": "Prostate Cancer",
                    "relevance": "HIGH"
                },
                {
                    "id": "M29464",
                    "name": "Lower Urinary Tract Symptoms",
                    "asFound": "Lower Urinary Tract Symptoms",
                    "relevance": "HIGH"
                },
                {
                    "id": "M8946",
                    "name": "Genital Neoplasms, Male",
                    "relevance": "LOW"
                },
                {
                    "id": "M17315",
                    "name": "Urogenital Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M2876",
                    "name": "Genital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M8944",
                    "name": "Genital Diseases, Male",
                    "relevance": "LOW"
                },
                {
                    "id": "M2875",
                    "name": "Urogenital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M14333",
                    "name": "Prostatic Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M27095",
                    "name": "Male Urogenital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M22659",
                    "name": "Urological Manifestations",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC04",
                    "name": "Neoplasms"
                },
                {
                    "abbrev": "BXS",
                    "name": "Urinary Tract, Sexual Organs, and Pregnancy Conditions"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                }
            ]
        }
    },
    "hasResults": false
}